Neutrophil to lymphocyte and monocyte to high-density lipoprotein ratios are promising inflammatory indicators of bipolar disorder

References

• Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543–552.
   PubMed Web of Science ®Google Scholar
• Alonso J, Petukhova M, Vilagut G, et al. Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Mol Psychiatry. 2011;16(12):1234–1246.
   PubMed Web of Science ®Google Scholar
• Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804–817.
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, McIntyre RS. Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci. 2017;7(12):144.
   PubMed Web of Science ®Google Scholar
• Benedetti F, Aggio V, Pratesi ML, et al. Neuroinflammation in bipolar depression. Front Psychiatry. 2020;11:71.
   PubMed Web of Science ®Google Scholar
• Misiak B, Bartoli F, Carra G, et al. Chemokine alterations in bipolar disorder: a systematic review and meta-analysis. Brain Behav Immun. 2020;88:870–877.
   PubMed Web of Science ®Google Scholar
• Evers A-K, Veeh J, McNeill R, Kittel-Schneider S, et al. C-reactive protein concentration in bipolar disorder: association with genetic variants. Int J Bipolar Disord. 2019;7(1):1–9.
   PubMed Web of Science ®Google Scholar
• Mazza MG, Lucchi S, Tringali AGM, et al. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84:229–236.
   PubMed Web of Science ®Google Scholar
• Wang J-R, Chen Z, Yang K, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12(1):1–10.
   PubMed Web of Science ®Google Scholar
• Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5(1):2–6.
   PubMedGoogle Scholar
• Li BO, Zhou P, Liu Y, et al. Platelet-to-lymphocyte ratio in advanced cancer: review and meta-analysis. Clin Chim Acta. 2018;483:48–56.
   PubMed Web of Science ®Google Scholar
• Rosales C. Neutrophil: a cell with many roles in inflammation or several cell types? Front Physiol. 2018;9:113.
   PubMed Web of Science ®Google Scholar
• Horstman LL, Jy W, Ahn YS, et al. Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation. 2010;7(1):10–22.
   PubMedGoogle Scholar
• Baufeld C, O'Loughlin E, Calcagno N, et al. Differential contribution of microglia and monocytes in neurodegenerative diseases. J Neural Transm. 2018;125(5):809–826.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Cai T, Fan L, et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis. 2020;95:332–339.
   PubMed Web of Science ®Google Scholar
• Jacomb I, Stanton C, Vasudevan R, et al. C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Front Immunol. 2018;9:2230.
   PubMed Web of Science ®Google Scholar
• Özdin S, Böke Ö. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia. Psychiatry Res. 2019;271:131–135.
   PubMed Web of Science ®Google Scholar
• Kuyumcu ME, Yesil Y, Oztürk ZA, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;34(2):69–74.
   PubMed Web of Science ®Google Scholar
• Inanli I, Aydin M, Çaliskan AM, et al. Neutrophil/lymphocyte ratio, monocyte/lymphocyte ratio, and mean platelet volume as systemic inflammatory markers in different states of bipolar disorder. Nord J Psychiatry. 2019;73(6):372–379.
   PubMed Web of Science ®Google Scholar
• Çakır U, Tuman TC, Yıldırım O. Increased neutrophil/lymphoctye ratio in patients with bipolar disorder: a preliminary study. Psychiatr Danub. 2015;27(2):0–184.
   Web of Science ®Google Scholar
• Kalelioglu T, Akkus M, Karamustafalioglu N, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder. Psychiatry Res. 2015;228(3):925–927.
   PubMed Web of Science ®Google Scholar
• Kirlioglu SS, Balcioglu YH, Kalelioglu T, et al. Comparison of the complete blood count-derived inflammatory markers in bipolar patients with manic and mixed episodes. Clin Study. 2019;195:199.
   Google Scholar
• Özdin S, Usta MB. A comparison of inflammatory markers in manic and euthymic states of bipolar disorder. Nord J Psychiatry. 2021;75(2):124–129.
   PubMed Web of Science ®Google Scholar
• Ivković M, Pantović-Stefanović M, Dunjić-Kostić B, et al. Neutrophil-to-lymphocyte ratio predicting suicide risk in euthymic patients with bipolar disorder: moderatory effect of family history. Compr Psychiatry. 2016;66:87–95.
   PubMed Web of Science ®Google Scholar
• Barter PJ, Nicholls S, Rye K-A, et al. Antiinflammatory properties of HDL. Circ Res. 2004;95(8):764–772.
   PubMed Web of Science ®Google Scholar
• Abacioglu OO. Monocyte to high-density lipoprotein ratio: a prognostic factor for mitral valve prolapse? Bratisl Lek Listy. 2020;121(2):151–153.
   PubMed Web of Science ®Google Scholar
• Sahpolat M, Ayar D, Ari M, et al. Elevated monocyte to high-density lipoprotein ratios as an inflammation markers for schizophrenia patients. Clin Psychopharmacol Neurosci. 2021;19(1):112–116.
   PubMed Web of Science ®Google Scholar
• Çalişkan AM, Çokünlü Y. Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the manic state of bipolar disorder. Fam Pract Palliat Care. 2021;6(2):81–85.
   Google Scholar
• Pandey GN, Ren X, Rizavi HS, et al. Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder. Bipolar Disord. 2015;17(6):636–644.
   PubMed Web of Science ®Google Scholar
• Mazza MG, Tringali AGM, Rossetti A, et al. Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders. Gen Hosp Psychiatry. 2019;58:7–12.
   PubMed Web of Science ®Google Scholar
• Giynas Ayhan M, Cicek IE, Inanli I, et al. Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder. Psychiatry Clin Psychopharmacol. 2017;27(3):278–282.
   Web of Science ®Google Scholar
• Dargél AA, Godin O, Kapczinski F, et al. C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry. 2015;76(2):3919.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Steiner J, Molendijk ML, et al. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(12):1147–1156.
   PubMed Web of Science ®Google Scholar
• Cunha AB, Andreazza AC, Gomes FA, et al. Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosc. 2008;258(5):300–304.
   PubMed Web of Science ®Google Scholar
• Khandaker GM, Pearson RM, Zammit S, et al. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71(10):1121–1128.
   PubMed Web of Science ®Google Scholar
• Wium-Andersen MK, Ørsted DD, Nielsen SF, et al. Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals. JAMA Psychiatry. 2013;70(2):176–184.
   PubMed Web of Science ®Google Scholar
• Köhler-Forsberg O, Buttenschøn HN, Tansey KE, et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017;62:344–350.
   PubMed Web of Science ®Google Scholar
• Pereira AC, Oliveira J, Silva S, et al. Inflammation in bipolar disorder (BD): identification of new therapeutic targets. Pharmacol Res. 2021;163(1):105325.
   PubMedGoogle Scholar
• Edberg D, Hoppensteadt D, Walborn A, et al. Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. J Psychiatr Res. 2018;102(1):1–7.
   PubMedGoogle Scholar
• Ganjali S, Gotto AM Jr Ruscica M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237–9246.
   PubMed Web of Science ®Google Scholar
• Acikgoz N, Kurtoğlu E, Yagmur J, et al. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet disease. Angiology 2018;69(1):65–70.
   PubMed Web of Science ®Google Scholar